Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 48, 165-169, January 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strickland, J. E.
Right arrow Articles by Yuspa, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strickland, J. E.
Right arrow Articles by Yuspa, S. H.

Development of Murine Epidermal Cell Lines Which Contain an Activated rasHa Oncogene and Form Papillomas in Skin Grafts on Athymic Nude Mouse Hosts

James E. Strickland1, David A. Greenhalgh, Aneta Koceva-Chyla2, Henry Hennings, Clara Restrepo, Michael Balaschak and Stuart H. Yuspa

Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, and ImmuQuest Laboratories, Rockville, Maryland 20850

We have developed four murine epidermal cell lines which form squamous papillomas when grafted to athymic nude mice in a reconstituted skin. Two of the lines, SP-1 and BP-4, were derived from pools of papillomas produced on SENCAR and BALB/c mouse skin, respectively, by initiation with 7,12-dimethylbenz(a)anthracene and promotion with 12-O-tetradecanoylphorbol-13-acetate. Line 308 was derived from BALB/c mouse skin initiated in vivo with 7,12-dimethylbenz(a)anthracene, culture of the epidermal cells, and selection of cells resistant to Ca2+-induced terminal differentiation. Line LC14 was derived from untreated, cultured newborn BALB/c mouse primary epidermal cells which spontaneously developed resistance to Ca2+-induced terminal differentiation. Each line has an activated rasHa gene with a mutation within codon 61. Cells from all four lines, in contrast to normal primary epidermal cells, survive in medium with Ca2+ levels > 0.1 mM. Clonal growth studies in culture showed a unique growth pattern for each of the four lines in medium with 1.4 mM and 0.05 mM Ca2+, with or without 12-O-tetradecanoylphorbol-13-acetate. Early passage cells of these lines should provide a valuable resource for detecting genes or genetic alterations which complement an activated ras gene to cause malignant conversion and for studying the biology of tumor promotion.

1 To whom requests for reprints should be addressed, at Room 3B25, Building 37, NIH, Bethesda, MD 20892.

2 Supported by the United States-Poland Scientific Exchange Program.

Received 6/24/87. Revised 9/22/87. Accepted 10/ 7/87.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
D. Schweiger, G. Furstenberger, and P. Krieg
Inducible expression of 15-lipoxygenase-2 and 8-lipoxygenase inhibits cell growth via common signaling pathways
J. Lipid Res., March 1, 2007; 48(3): 553 - 564.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Tong, R. T. Van Dross, A. Abu-Yousif, A. R. Morrison, and J. C. Pelling
Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational Inhibition
Mol. Cell. Biol., January 1, 2007; 27(1): 283 - 296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. V. Wattenberg
Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C24 - C32.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Patel, Z. F. Xi, E. Y. Seo, D. McGaughey, and J. A. Segre
Klf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisition
PNAS, December 5, 2006; 103(49): 18668 - 18673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Rhiemeier, U. Breitenbach, K. H. Richter, C. Gebhardt, I. Vogt, B. Hartenstein, G. Furstenberger, C. Mauch, J. Hess, and P. Angel
A Novel Aspartic Proteinase-Like Gene Expressed in Stratified Epithelia and Squamous Cell Carcinoma of the Skin
Am. J. Pathol., April 1, 2006; 168(4): 1354 - 1364.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Li, K. Sampat, N. Hu, J. Zakari, and S. H. Yuspa
Protein Kinase C Negatively Regulates Akt Activity and Modifies UVC-induced Apoptosis in Mouse Keratinocytes
J. Biol. Chem., February 10, 2006; 281(6): 3237 - 3243.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L.-H. Gu and P. A. Coulombe
Defining the Properties of the Nonhelical Tail Domain in Type II Keratin 5: Insight from a Bullous Disease-causing Mutation
Mol. Biol. Cell, March 1, 2005; 16(3): 1427 - 1438.
[Abstract] [Full Text] [PDF]


Home page
Genome Res.Home page
N. Martin, S. Patel, and J. A. Segre
Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in coordinate regulation
Genome Res., December 1, 2004; 14(12): 2430 - 2438.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. K. Warmka, L. J. Mauro, and E. V. Wattenberg
Mitogen-activated Protein Kinase Phosphatase-3 Is a Tumor Promoter Target in Initiated Cells That Express Oncogenic Ras
J. Biol. Chem., August 6, 2004; 279(32): 33085 - 33092.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-S. Seong, C. Min, L. Li, J. Y. Yang, S.-Y. Kim, X. Cao, K. Kim, S. H. Yuspa, H.-H. Chung, and K. S. Lee
Characterization of a Novel Cyclin-Dependent Kinase 1 Inhibitor, BMI-1026
Cancer Res., November 1, 2003; 63(21): 7384 - 7391.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Van Dross, Y. Xue, A. Knudson, and J. C. Pelling
The Chemopreventive Bioflavonoid Apigenin Modulates Signal Transduction Pathways in Keratinocyte and Colon Carcinoma Cell Lines
J. Nutr., November 1, 2003; 133(11): 3800S - 3804.
[Abstract] [Full Text] [PDF]


Home page
Crit. Rev. Oral Biol. Med.Home page
W. C. Weinberg and M. F. Denning
P21WAF1 CONTROL OF EPITHELIAL CELL CYCLE AND CELL FATE
Crit. Rev. Oral. Biol. Med., November 1, 2002; 13(6): 453 - 464.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Fernandez-Salas, K. S. Suh, V. V. Speransky, W. L. Bowers, J. M. Levy, T. Adams, K. R. Pathak, L. E. Edwards, D. D. Hayes, C. Cheng, et al.
mtCLIC/CLIC4, an Organellular Chloride Channel Protein, Is Increased by DNA Damage and Participates in the Apoptotic Response to p53
Mol. Cell. Biol., June 1, 2002; 22(11): 3610 - 3620.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. S. Bellows, M. Howell, C. Pearson, S. A. Hazlewood, and J. M. Hardwick
Epstein-Barr Virus BALF1 Is a BCL-2-Like Antagonist of the Herpesvirus Antiapoptotic BCL-2 Proteins
J. Virol., March 1, 2002; 76(5): 2469 - 2479.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Hatoum, M. E. El-Sabban, J. Khoury, S. H. Yuspa, and N. Darwiche
Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis
Carcinogenesis, December 1, 2001; 22(12): 1955 - 1963.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. McVean, H. Xiao, K.-i. Isobe, and J. C. Pelling
Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes
Carcinogenesis, April 1, 2000; 21(4): 633 - 639.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Glick, N. Popescu, V. Alexander, H. Ueno, E. Bottinger, and S. H. Yuspa
Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes
PNAS, December 21, 1999; 96(26): 14949 - 14954.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Fernandez-Salas, M. Sagar, C. Cheng, S. H. Yuspa, and W. C. Weinberg
p53 and Tumor Necrosis Factor alpha Regulate the Expression of a Mitochondrial Chloride Channel Protein
J. Biol. Chem., December 17, 1999; 274(51): 36488 - 36497.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Li, P. S. Lorenzo, K. Bogi, P. M. Blumberg, and S. H. Yuspa
Protein Kinase Cdelta Targets Mitochondria, Alters Mitochondrial Membrane Potential, and Induces Apoptosis in Normal and Neoplastic Keratinocytes When Overexpressed by an Adenoviral Vector
Mol. Cell. Biol., December 1, 1999; 19(12): 8547 - 8558.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Gupta, S. F. Rosenberger, and G. T. Bowden
Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines
Carcinogenesis, November 1, 1999; 20(11): 2063 - 2073.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Liu, N. M. Wikonkal, and D. E. Brash
Induction of cyclin-dependent kinase inhibitors and G1 prolongation by the chemopreventive agent N-acetylcysteine
Carcinogenesis, September 1, 1999; 20(9): 1869 - 1872.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Rajesh, K. Schell, and A. K. Verma
Ras Mutation, Irrespective of Cell Type and p53 Status, Determines a Cell's Destiny to Undergo Apoptosis by Okadaic Acid, an Inhibitor of Protein Phosphatase 1 and 2A
Mol. Pharmacol., September 1, 1999; 56(3): 515 - 525.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Hattori, T. H. Sisson, Y. Xu, T. J. Desai, and R. H. Simon
Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung
Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L573 - L579.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. F. Rosenberger, J. S. Finch, A. Gupta, and G. T. Bowden
Extracellular Signal-regulated Kinase 1/2-mediated Phosphorylation of JunD and FosB Is Required for Okadaic Acid-induced Activator Protein 1 Activation
J. Biol. Chem., January 8, 1999; 274(2): 1124 - 1130.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1988 by the American Association for Cancer Research.